Find Support With:
Abnormal Newborn Screening Results and Additional Testing
If your baby’s newborn screening results are abnormal, your baby will need to have another test. Not every abnormal result means your baby has a disorder. It is important to have quick follow-up testing. Without treatment, Glutaric Acidemia, Type 2 can result in harmful effects soon after birth.
The Utah Newborn Screening Program will contact you and your child’s pediatrician for blood and urine testing.
The Metabolic Clinic at Primary Children’s Hospital cares for babies diagnosed with Glutaric Acidemia, Type 2.
About Glutaric Acidemia, Type 2
People affected by Glutaric Acidemia, Type 2 are not able to break down certain fats and proteins. This causes too many unused fatty acids and other harmful substances to build up in the body.
If untreated, Glutaric Acidemia, Type 2 can cause weak muscle tone, heart problems, and death. For some people, early detection and treatment of Glutaric Acidemia, Type 2 can prevent some of these complications.
Frequency
Glutaric Acidemia, Type 2 affects approximately 1 in 250,000 individuals in the United States.
Condition Type
Glutaric Acidemia, Type 2 is a Fatty Acid Oxidation Disorder.
Also Known As
GA-2, EMA, ETFA, ETFB, or ETFDH Deficiency, Type II, MAD, MADD, Electron Transfer Flavoprotein Deficiency, Multiple Acyl-CoA Dehydrogenase Deficiency, Multiple FAD Dehydrogenase Deficiency, C5, C4